Apellis Pharmaceuticals, Inc.

Bank of New York Mellon Corp APLS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

271,925

Value ($000)

6,831

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	6,831	0.0%	271,925	12/31/2025
2025 Q3	11/3/2025	5,617	0.0%	248,194	9/30/2025
2025 Q2	8/5/2025	4,212	0.0%	243,327	6/30/2025
2025 Q1	4/29/2025	7,199	0.0%	329,173	3/31/2025
2024 Q4	2/4/2025	10,671	0.0%	334,416	12/31/2024
2024 Q3	11/12/2024	9,913	0.0%	343,739	9/30/2024
2024 Q2	7/25/2024	13,242	0.0%	345,195	6/30/2024
2024 Q1	4/25/2024	18,981	0.0%	322,922	3/31/2024
2023 Q4	1/29/2024	22,283	0.0%	372,255	12/31/2023
2023 Q3	10/24/2023	13,705	0.0%	360,287	9/30/2023
2023 Q2	8/3/2023	32,549	0.0%	357,289	6/30/2023
2023 Q1	5/9/2023	25,882	0.0%	392,396	3/31/2023
2022 Q4	2/14/2023	20,945	0.0%	405,039	12/31/2022
2022 Q3	11/14/2022	27,898	0.0%	408,459	9/30/2022
2022 Q2	8/15/2022	15,743	0.0%	348,150	6/30/2022
2022 Q1	5/11/2022	16,029	0.0%	315,480	3/31/2022
2021 Q4	2/11/2022	14,098	0.0%	298,193	12/31/2021
2021 Q3	11/18/2021	8,882	0.0%	269,484	9/30/2021
2021 Q2	8/11/2021	16,560	0.0%	262,028	6/30/2021
2021 Q1	5/13/2021	9,746	0.0%	227,134	3/31/2021
2020 Q4	2/9/2021	14,541	0.0%	254,207	12/31/2020
2020 Q3	11/12/2020	7,191	0.0%	238,360	9/30/2020
2020 Q2	8/12/2020	7,957	0.0%	243,640	6/30/2020
2020 Q1	5/6/2020	6,430	0.0%	240,019	3/31/2020
2019 Q4	2/14/2020	6,008	0.0%	196,199	12/31/2019